Abstract
Creatine in its free and phosphorylated form plays an essential role for maintenance and distribution of ATP levels in tissues with high and fluctuating energy demands such as muscle, brain and heart. Alterations in the creatine concentration in these tissues produce marked functional changes. Creatine concentration is largely determined by a specific creatine transporter, a member of the Na+ dependent transporters family, that is localized on the cells plasma membrane. This transporter is needed to carry creatine into the cells against a high concentration gradient. In recent years the mechanisms regulating the expression and the function of this transporter are being unraveled. Even if our knowledge of this matter is still limited, we have now tools for either stimulating or inhibiting this transporter, tools that may be relevant to several experimental and clinical conditions. This review will examine the data and the tools that are available in relation to the regulation and expression of the creatine transporter. Furthermore, we will briefly review the possible practical relevance of manipulating the creatine transporter activity.
Keywords: Creatine, phosphocreatine, creatine transporter, SLC6A8, inhibition, stimulation
Current Enzyme Inhibition
Title: Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter
Volume: 5 Issue: 4
Author(s): Maurizio Balestrino, Carlo Gandolfo and Luisa Perasso
Affiliation:
Keywords: Creatine, phosphocreatine, creatine transporter, SLC6A8, inhibition, stimulation
Abstract: Creatine in its free and phosphorylated form plays an essential role for maintenance and distribution of ATP levels in tissues with high and fluctuating energy demands such as muscle, brain and heart. Alterations in the creatine concentration in these tissues produce marked functional changes. Creatine concentration is largely determined by a specific creatine transporter, a member of the Na+ dependent transporters family, that is localized on the cells plasma membrane. This transporter is needed to carry creatine into the cells against a high concentration gradient. In recent years the mechanisms regulating the expression and the function of this transporter are being unraveled. Even if our knowledge of this matter is still limited, we have now tools for either stimulating or inhibiting this transporter, tools that may be relevant to several experimental and clinical conditions. This review will examine the data and the tools that are available in relation to the regulation and expression of the creatine transporter. Furthermore, we will briefly review the possible practical relevance of manipulating the creatine transporter activity.
Export Options
About this article
Cite this article as:
Balestrino Maurizio, Gandolfo Carlo and Perasso Luisa, Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter, Current Enzyme Inhibition 2009; 5 (4) . https://dx.doi.org/10.2174/157340809789630299
DOI https://dx.doi.org/10.2174/157340809789630299 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons
CNS & Neurological Disorders - Drug Targets MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry Metabotropic GABAB Receptors New Challenges in Drug Design
Current Medicinal Chemistry - Central Nervous System Agents The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research Does Mechanism of Drug Action Matter to Inform Rational Polytherapy in Epilepsy?
CNS & Neurological Disorders - Drug Targets Neurological Disorders in Pregnancy
Current Women`s Health Reviews Glial Modulation of GABAergic and Glutamat ergic Neurotransmission
Current Topics in Medicinal Chemistry Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Malononitrile as a Key Reagent in Multicomponent Reactions for the Synthesis of Pharmaceutically Important Pyridines
Current Organic Chemistry KMC, Concepts, Definitions and Praxis: What Elements are Applicable in What Settings in Which Local Circumstances?
Current Women`s Health Reviews Xenobiotic Acyl Glucuronides and Acyl CoA Thioesters as Protein- Reactive Metabolites With the Potential to Cause Idiosyncratic Drug Reactions
Current Drug Metabolism The Influence of Vaccine on Febrile Seizure
Current Neuropharmacology Clinical and Electroencephalographic Assessment of Cefepime During Treatment of Nosocomial Infections in Neurological Patients
Central Nervous System Agents in Medicinal Chemistry Developing Pharmacotherapies for Cannabis and Cocaine Use Disorders
Current Neuropharmacology Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design Neurotransmitter Regulation of Adult Neurogenesis: Putative Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Microglial Polarization to Improve TBI Outcomes
CNS & Neurological Disorders - Drug Targets